Response to letter to the Editor: "Similarity between studies of dihydromyricetin and resveratrol for NAFLD"

Pharmacol Res. 2015 Oct:100:321. doi: 10.1016/j.phrs.2015.07.035. Epub 2015 Aug 20.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Blood Glucose / drug effects*
  • Female
  • Humans
  • Insulin Resistance*
  • Lipid Metabolism / drug effects*
  • Male
  • Non-alcoholic Fatty Liver Disease / drug therapy*
  • Stilbenes / pharmacology*

Substances

  • Blood Glucose
  • Stilbenes